Agennix | Evaluate

EP Vantage interview – Big series A backs Inotrem’s early sepsis drug

January 09, 2013

Sarepta joins the big league as best-performing 2012 share

October 10, 2012

Wockardt and Arena lead small-cap gainers through nine months

August 07, 2012

Agennix facing tough questions about its future following talactoferrin failure

July 20, 2012

Key data readouts in the second half of 2012

April 05, 2012

Vivus, Amylin and Threshold notable small cap gainers in Q1

February 02, 2012

Agennix’s failure in sepsis leaves few future options

July 07, 2011

EP Vantage Interview - Agennix hoping for success with multitasking talactoferrin

May 24, 2011

Eli Lilly finds new home for sepsis treatment Xigris

January 25, 2011

Eritoran failure overshadows eventful few days for Eisai

December 21, 2010

Who were the cash call kings of 2010?

Load More